|
Dr. Jones is an Adjunct Professor of Medicine at Tufts University School of Medicine in Boston, Massachusetts and is President/CEO of JMI Laboratories in North Liberty, Iowa, USA. Dr. Jones obtained his medical degree from the University of Oregon, where he also served an internship and residency in Anatomic and Clinical Pathology. He is board certified in anatomic and clinical pathology by the American Board of Pathology. He is a fellow in the American Society of Clinical Pathologists, the College of American Pathologists, the American Academy of Microbiology, the Infectious Disease Society of America and numerous other organizations. He has served on or chaired numerous committees or subcommittees of the Clinical and Laboratory Standards Institute (formerly the National Committee for Clinical Laboratory Standards) over the last 25 years (recipient of the Eilers Award in 2001, the highest award given by the CLSI), and is also a member of the advisory council for antimicrobial agents of the U.S. Pharmacopeia. Dr. Jones has authored over 1,300 peer-reviewed publications on a variety of topics relating to the comprehensive evaluation of new antimicrobial agents, antimicrobial susceptibility test development, and resistance mechanisms and their phenotypic expression or molecular epidemiology. He has also authored a number of book chapters, hundreds of abstracts, pamphlets, and monographs, sits on the editorial board of several international peer-reviewed journals, and is currently the Editor-in-Chief of Diagnostic Microbiology and Infectious Disease, a well known international publication. He has been the principal global investigator for the SENTRY Antimicrobial Surveillance Program and the MYSTIC Programme (1997-present), as well as a regional monitor for other resistance surveillance networks (ZAPS, ZAAPS, SMART, LEADER, SPAR, SCOPE etc). | 